Stock Region Penny Picks
Stock Region Watchlist Newsletter - Sunday, January 12, 2025.
Stock Region Watchlist Newsletter - Sunday, January 12, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information contained in this newsletter is for informational purposes only and does not constitute financial advice. Stock Region does not endorse or recommend any securities and is not liable for any investment decisions made based on this information. Please conduct your own research and consult with a financial advisor before making any investment decisions.
$AKYA - Quanterix to Acquire Akoya Biosciences
Quanterix announced the acquisition of Akoya Biosciences, aiming to create the first integrated solution for ultra-sensitive detection of both blood- and tissue-based protein biomarkers. This move could strengthen their leadership in biomarker detection technology.
$IVVD - Invivyd's PEMGARDA™ Shows Promise
Invivyd reported the continued neutralizing activity of PEMGARDA™ (pemivibart) against the dominant SARS-CoV-2 variant XEC. This highlights the success of PEMGARDA™'s potential in tackling evolving COVID-19 variants.
$NBY - NovaBay Pharmaceuticals Trademark Sale
NovaBay finalized the sale of its wound care trademarks—NeutroPhase, PhaseOne, and OmniPhase—to Phase One Health for $500,000. This allows the company to focus on its core business areas.
$ZENA - ZenaDrone Applies for FAA Certification
ZenaTech is pushing innovation with its ZenaDrone, applying for FAA Part 137 Crop Sprayer Certification. The drone is designed to address needs in agriculture and wildfire management, showcasing its versatility.
$DTIL - HC Wainwright Maintains Precision BioSciences Rating
HC Wainwright reiterated its "Buy" rating for Precision BioSciences ($DTIL), maintaining a $60 price target. This reflects confidence in the company’s future performance and growth potential.
$JFBR - Jeffs' Brands Targets Revenue Growth
Jeffs' Brands anticipates over 120% revenue growth since its 2022 IPO, aiming for $20 million in revenue for 2025. This projection positions them as a company worth watching.
$AIFF - Positive Results from SP-624 Study
Arrivo BioVentures announced promising results from its study of SP-624 on brain activity related to depression and cognition. This could mark a milestone in depression treatment innovation.
$HOVR - Horizon Aircraft Expands with Letter of Intent
Horizon Aircraft signed an LOI with Discovery Air Chile Ltda. to expand the presence of its Cavorite X7 Hybrid eVTOLs globally. A big step forward in hybrid electric aviation technology.
$VSEE - VSee Health Lands Major Contract
VSee Health strengthened its foothold in the healthcare sector by securing a significant contract with a Florida health system to provide tele-nursing and home health services.
$AREB - American Rebel Delivers Light Beer Shipment
American Rebel Holdings delivered their first shipment of American Rebel Light Beer to a Kentucky distributor. The company is looking to grow its presence in the beverage market.
$GRYP - Gryphon Digital Mining’s Green Energy Expansion
Gryphon Digital Mining signed an agreement to scale its HPC/AI asset to 4GW of green energy via natural gas and carbon sequestration. A notable move in sustainable tech development.
$ONMD - OneMedNet Regains NASDAQ Compliance
OneMedNet announced its compliance with NASDAQ’s minimum bid price requirements, securing its place on the exchange.
$SPI - SPI Energy Settlement Agreement
SPI Energy reached a settlement agreement with SINSIN, a significant step that may resolve legal uncertainties and shift focus back to its business objectives.
$MSW IPO - Ming Shing Group Holdings Limited
Hong Kong-based Ming Shing Group Holdings specializes in wet trades works like plastering, tile laying, and marble works. They aim to lead Hong Kong’s construction industry through quality and reliability.
$BAER - Former CEO Moves to the U.S. Senate
Earlier this week, $BAER’s founder and former CEO was sworn in as a U.S. Senator for Montana, potentially influencing policy-making that could impact the company’s operations.
$XTIA - Offering Closed
XTIA announced the closing of its best-efforts offering with 1,454,546 shares priced at $13.75 per share post a 1-for-250 reverse stock split.
$TRAW - Progress in H5N1 Bird Flu Antiviral
Traws Pharma and its partner, Expert Systems, announced a breakthrough in their antiviral program for the H5N1 bird flu. Watch for developments in this closely monitored health concern.
Keep an eye on these updates— opportunities could be just around the corner!
Disclaimer: This newsletter is intended solely for informational purposes. The mention of specific companies or stocks does not imply a recommendation to buy, sell, or hold any security. Please make investment decisions based on careful consideration and consultation with your financial advisor.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net